Lymphedema-distichiasis (LD) is a dominantly inherited syndrome with onset of lymphedema at or just after puberty. Most affected individuals have distichiasis-fine hairs arising inappropriately from the eyelid meibomian glands-which is evident from birth. A study of three families with LD has shown linkage to chromosome 16q24.3, and subsequent analysis of the region for recombinant genes places the locus between D16S422 and D16S3074, a distance of approximately 16 cM. Possible candidate genes in this interval include the N-proteinase for type 3 collagen, PCOLN3; the metalloprotease PRSM1; and the cell matrix-adhesion regulator, CMAR.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1377941 | PMC |
| http://dx.doi.org/10.1086/302500 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Clinical features and genetic analysis of two Chinese pedigrees affected with Lymphedema-Distichiasis syndrome].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
October 2024
Center for Medical Genetics and Prenatal Diagnosis, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
Article Synopsis
- - The study investigates the prenatal and postnatal features, along with genetic traits, of Lymphedema-Distichiasis syndrome (LDS) in two Chinese families with FOXC2 gene mutations.
- - Genetic analysis revealed pathogenic variants in the FOXC2 gene for both families, with literature review yielding a total of 117 identified LDS patients, including prenatal signs in 13 cases and postnatal manifestations in 110.
- - Key prenatal symptoms of LDS include increased nuchal translucency and fetal edema, while postnatal symptoms commonly feature distichiasis and lymphedema, with only a few cases exhibiting signs before and after birth.
Pharmacological inhibition of FOXO1 promotes lymphatic valve growth in a congenital lymphedema mouse model.
Front Cell Dev Biol
January 2023
Department of Molecular Pharmacology & Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.
Article Synopsis
- * The transcription factor FOXO1 inhibits the formation of lymphatic valves by suppressing valve-forming gene expression, making it a potential target for lymphedema treatments.
- * The FOXO1 inhibitor AS1842856 was shown to significantly boost valve-forming gene expression in human lymphatic endothelial cells and increased the number of lymphatic valves in a mouse model of lymphedema, suggesting it may be an effective approach for treating valve defects.
Haploinsufficiencies of FOXF1, FOXC2 and FOXL1 genes originated from deleted 16q24.1q24.2 fragment related with alveolar capillary dysplasia with misalignment of pulmonary veins and lymphedema-distichiasis syndrome: relationship to phenotype.
Mol Cytogenet
November 2022
Department of Prenatal Diagnosis Medical Center, Xuzhou Central Hospital, No. 199 South Jiefang Road, Xuzhou, 221009, Jiangsu, China.
Article Synopsis
- A fetus was identified with a 2.12-Mb deletion on chromosome 16, leading to two serious conditions: alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) and lymphedema-distichiasis syndrome (LDS).
- The fetus showed multiple structural abnormalities during an ultrasound at around 24 weeks of gestation, prompting genetic testing through amniocentesis.
- The results revealed a deletion indicating a genetic issue, emphasizing the need for genomic testing as a primary diagnostic approach for fetuses with structural problems.
Genetic landscape of FOXC2 mutations in lymphedema-distichiasis syndrome: Different mechanism of pathogenicity for mutations in different domains.
Exp Eye Res
September 2022
Health Management Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China; Sichuan Provincial Key Laboratory for Human Disease Gene Study and Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China; Research Unit for Blindness Prevention of Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Sichuan, China. Electronic address:
Article Synopsis
- Lymphedema-dissociated syndrome (LDS) is a condition linked to mutations in the FOXC2 gene, which have unclear effects on its development.
- The study examined mutations in FOXC2 found in two Chinese families, using various lab techniques to analyze their impact on gene function and lymphatic vessel formation.
- Results showed that several mutations led to reduced DNA binding and transcription abilities, affecting key pathways like ERK-RAS and Wnt4 signaling, potentially explaining some developmental issues associated with LDS.
Distichiasis: An update on etiology, treatment and outcomes.
Indian J Ophthalmol
April 2022
Ocular Surface and Adnexa Services; Centre for Ocular Regeneration (CORE), L V Prasad Eye Institute, Hyderabad, Telangana, India.
Article Synopsis
- - Distichiasis is a condition where an extra row of eyelashes grows from the meibomian gland openings, either from congenital conditions like lymphedema distichiasis syndrome or secondary to issues like cicatrizing conjunctivitis.
- - The review discusses the causes, symptoms, and the evolution of surgical treatments for distichiasis, highlighting that while various treatment options exist, success rates are often between 50%-60%, especially for acquired cases.
- - Treatments like electroepilation and cryotherapy are less effective compared to surgical excision, with better outcomes noted for methods like marginal tarsectomy; however, the exact nature of distichiasis lashes and their management remains inadequately understood.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!